Antibiotic-resistant bacteria pose a serious and growing threat.

“These are superbugs that people die from,” says Erin Duffy, chief scientific officer of Melinta Therapeutics and CURE board member. “We’re not going to solve the antibiotic resistance problem with the introduction of the next new antibiotic. We’re going to need sustained commitment, flexibility, enthusiasm and passion to really make a difference.”

Click the link below to see a video in which Erin explains how information sharing can help researchers with antibiotic discovery — and why we need a holistic approach to build a new generation of antibiotics for the future.